Velocity Clinical Research, Lafayette ( Site 0103) — Lafayette, Louisiana

Public research footprint of Velocity Clinical Research, Lafayette ( Site 0103), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

SARS-CoV-2 · Influenza · Respiratory Syncytial Virus Infections · Functional Constipation (FC)

Recently updated registry entries

NCT06904274 — Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months (Withdrawn)
NCT05655182 — A Study of BLB-201 RSV Vaccine in Infants and Children (Recruiting)
NCT07231419 — Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Velocity Clinical Research, Lafayette ( Site 0103)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.